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 2 
ABSTRACT 31 
Background: Unicompartmental knee replacement (UKR) offers advantages over total knee 32 
replacement but has higher revision rates. New instrumentation known as Microplasty was 33 
introduced to address this. The aim was to compare the revision rates of UKRs implanted 34 
with Microplasty and traditional instrumentation (Non-Microplasty). 35 
 36 
Methods: National Joint Registry (NJR) data was used to propensity score match 15,906 37 
UKRs (7,953 Microplasty and 7,953 Non-Microplasty) for important patient, implant and 38 
surgical factors. Implant survival rates were determined using the Kaplan-Meier method and 39 
compared using Cox regression models in a multilevel model. 40 
 41 
Results: The 5 year implant survival for Microplasty and Non-Microplasty UKRs were 42 
96.7% (95% CI 96.0%-97.2%) and 94.5% (CI 93.8-95.1%) respectively. The revision rate for 43 
Microplasty UKR was significantly lower than that of Non-Microplasty UKRs (Hazard ratio 44 
(HR)=0.77, p=0.008). Compared with Non-Microplasty UKRs, the revision rate of 45 
Microplasty UKRs implanted during the year after introduction of Microplasty was lower but 46 
the difference was not significant  (HR 0.86, CI 0.67-1.10, p=0.23), whereas for those 47 
implanted more than a year after introduction the difference was significant (HR 0.69, CI 48 
0.54-0.89, p=0.004). 49 
 50 
Conclusion: The use of Microplasty instrumentation has resulted in an improved 5 year UKR 51 
survival.  Microplasty UKR implanted during the first year after introduction had a small, 52 
non-significant decrease in revision rate. As the revision rate did not increase this suggests 53 
that there is no adverse learning curve effect. Microplasty UKRs implanted after this 54 
transition period had a revision rate 31% lower than the Non-Microplasty group.  55 
 56 
Level of evidence: II 57 
Key words: Microplasty, Non Microplasty, Unicompartmental Knee Arthroplasty 58 







1. INTRODUCTION  65 
 66 
Total and Unicompartmental knee replacement (TKR, UKR) are the two main treatments for 67 
knee osteoarthritis which has failed to respond to conservative therapy, with evidence that 68 
UKR is appropriate in up to 50% of cases [1]. Although UKR is more cost effective [2] and 69 
results in better functional outcomes [3], revision rates remain significantly higher in joint 70 
registries [4-6]. This is not the case in specialist centres with high volume surgeons who 71 
achieve similar revision rates to TKR [7-9].  72 
 73 
The high revision rate of UKR may, in part, be a result of poor positioning of the implant or 74 
other technical problems with the operation, which is made particularly difficult with 75 
minimally invasive approaches where intra-operative visualisation is restricted [10, 11]. This 76 
is relevant given the most commonly used UKR is the Phase 3 Oxford UKR [4], which is 77 
implanted using a minimally invasive approach. Phase 3 instrumentation, which was 78 
introduced over 20 years ago, is difficult to use: For example the operating surgeon has to 79 
judge by eye the height of the tibial cut and the orientation of the femoral component, making 80 
inexperienced surgeons susceptible to errors. 81 
 82 
New instrumentation known as Microplasty was introduced to make the operation simpler, 83 
more reproducible and more reliable. The use of Microplasty instrumentation has been 84 
steadily increasing. The instrumentation includes a stylus system for selecting tibial resection 85 
level, a femoral drill guide linked to an intramedullary rod to help femoral component 86 
positioning, slotted saw guides and instruments to protect the medial collateral ligament and 87 
avoid impingement [12] (Figure 1). Although the Microplasty instrumentation has been 88 
shown to improve implant positioning [13-16] it is currently unknown whether it makes any 89 
difference to the revision rate. Additionally, as Microplasty instrumentation is more complex 90 
than the Phase 3 instrumentation (Non-Microplasty), there is a concern that the outcome 91 
might be worse when it is first used due to learning curve issues.  92 
 93 
The National Joint Registry for England, Wales, Northern Ireland and Isle of Man (NJR) is 94 
the world’s largest arthroplasty register [4]. NJR data was utilised to compare the revision 95 
rates following Microplasty and Non-Microplasty Oxford UKRs. The null hypothesis was 96 
that there would be no difference in UKR implant survival between groups. To ensure that 97 
any difference in implant performance was due to the instrumentation rather than other 98 
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factors, Microplasty and Non-Microplasty cases were matched on patient, surgeon (including 99 


































2. MATERIALS AND METHODS 133 
 134 
A retrospective observational study was performed using NJR data [4]. The NJR database 135 
includes information on patient factors (including age, sex, body mass index), implant factors 136 
(including component design and size) and surgical factors (surgical indication, operating 137 
surgeon grade) for each procedure. The database is linked to mortality data from the Office of 138 
National Statistics.  139 
 140 
The dates at which Microplasty Instrumentation was introduced to each UK hospital 141 
(changeover date) were obtained and supplied to the NJR. Prior to this date, or if there was no 142 
date, the hospital was assumed to be using the Non-Microplasty instrumentation. After this 143 
date it was assumed they were using Microplasty Instrumentation. During the first year after 144 
the changeover date it was assumed that there was a transition period which included the 145 
surgeon’s learning curve and the changeover between systems. In Oxford, prototype 146 
Microplasty instruments have been used for many years and there was no exact date of their 147 
changeover to Microplasty, so all UKRs conducted in Oxford were excluded from this study.  148 
 149 
Anonymised patient data were extracted from the NJR database which included all primary 150 
Oxford UKRs implanted between 1st January 2012 to 31st December 2017 (n=28,273), given 151 
Microplasty was first used outside Oxford in 2012. The NJR linked the changeover date to 152 
Microplasty to the patient data. After data cleaning there were 23,234 medial UKRs (11,024 153 
Microplasty and 12,210 Non Microplasty UKRs) eligible for study inclusion (Figure 2).  154 
 155 
Given the potential for patient, implant and surgical factors [17-31] other than 156 
instrumentation to affect the revision rate, a priori matching for these factors between groups 157 
was conducted using propensity scores (Table 1 for full list). Surgical factors included 158 
surgeon caseload, which was defined as the average number of UKRs done per year and 159 
stratified into low (<10 cases/yr), medium (10 to <30 cases/yr) and high volume (≥ 30 160 
cases/yr) as described previously [26].   161 
 162 
A multilevel logistic regression model was used to generate a propensity score representing 163 
the probability that a patient received a Microplasty assisted UKR. This approach controlled 164 
for clustering at the hospital level. The specific variables patients were matched on were; age, 165 
gender, primary diagnosis, unilateral/bilateral UKRs, ASA grade, chemical 166 
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thromboprophylaxis, mechanical thrombopropylaxis, operating surgeon grade, surgeon 167 
caseload, surgical approach, operating technique and implant fixation (Table 1). Body mass 168 
index (BMI) was not used for matching given it had a large proportion of missing data, but 169 
was similar between groups both before and after matching.  170 
 171 
One to one matching on the logit of the propensity score with a 0.02-SD calliper width was 172 
utilised. Greedy matching without replacement was used given its superior performance for 173 
estimating treatment effects [32]. Standardized mean differences (SMDs) were examined 174 
both before and after matching to assess for any covariate imbalance between the Microplasty 175 
and Non Microplasty UKRs, with SMDs of 10% or more considered suggestive of covariate 176 
imbalance [32]. After matching, 15,906 UKRs (7,953 Microplasty and 7,953 Non 177 
Microplasty UKRs) were included for analysis (Figure 2). Microplasty UKRs were divided 178 
into procedures conducted within the first year after Microplasty’s introduction and after the 179 
first year to explore the learning curve effect.  180 
 181 
2.1 Statistical analysis 182 
 183 
Outcomes of interest were: (1) implant survival and revision rates (2) indications for revision 184 
surgery.  185 
 186 
Cumulative implant survival was determined using the Kaplan-Meier method. The endpoint 187 
for implant survival was revision surgery (any component removed, exchanged or added). 188 
Cumulative implant revision rates were compared between groups, using Cox regression 189 
models. To account for clustering within the matched cohort a robust variance estimator was 190 
used in regression models. Univariable and adjusted models were also assessed. The adjusted 191 
models included covariates with residual imbalance after matching (SMD of 10% or more) 192 
[32].  193 
 194 
A secondary analysis was undertaken based on the revision rate per 100 component years. 195 
This was calculated for both groups by dividing the number of revisions by the total number 196 
of observed component years (mean follow up multiplied by number of knees) as per the 197 
Australian Joint Registry [5]. 95% CI were calculated using the Clopper Pearson exact 198 
method. Revision rates between groups were compared using the chi squared proportional 199 
test.  200 
 7 
 201 
To compare the indications for revision surgery the revision rates per 100 component years 202 
for each revision indication were calculated. The proportional Chi-squared test with Yate’s 203 
correction was used to test for differences between Microplasty and Non-Microplasty except 204 
when the observed frequencies were below 5 in which case the Fisher Exact Test was 205 
utilised. 206 
 207 
All statistical analyses were performed using Stata (Version 15.1; Lakeway Drive TX) except 208 
propensity score matching which was performed using R (Version 3.4.0; R Foundation for 209 
Statistical Computing, Vienna, Austria). P-values of <0.05 were considered significant, with 210 
95% confidence intervals (CI) presented. 211 
 212 
2.2 Ethics approval and consent to participate  213 
The study was approved by the NJR Research Sub-Committee (RSC2017/17). As patients 214 
provide informed consent for inclusion of their data in the NJR for purposes including research, 215 



















3. RESULTS  234 
 235 
The matched cohort included 15,906 UKRs with 7,953 Microplasty UKRs and 7,953 Non-236 
Microplasty UKRs. The mean age at surgery was 64.5 years (SD 9.5), with 7,235 females 237 
(45.5%) and 8,671 males (54.5%). The mean BMI was 30.4 kg/m2 (SD 5.0) with the primary 238 
indication for surgery being osteoarthritis in 15,752 knees (99.0%).   239 
 240 
Patient, surgical (including caseload) and implant characteristics were well balanced between 241 
the Microplasty and Non Microplasty groups after propensity score matching (Table 1). The 242 
only covariates with some residual imbalance were surgeon grade and surgeon caseload, which, 243 
when adjusted for in the regression models, did not change the findings.  244 
 245 
In the matched cohort, the mean follow up for Microplasty and Non Microplasty UKRs were 246 
2.3 years (SD 1.3) and 3.3 years (SD 1.8) respectively. In total 451 knees underwent revision 247 
surgery. There were 160 (2.0%) revisions in the Microplasty group and 291 (3.7%) revisions 248 
in the Non Microplasty UKR group.  249 
 250 
The 5-year cumulative implant survival rates were 96.7% (95% CI 96.0%-97.2%) for 251 
Microplasty and 94.5% (95% CI 93.8-95.1%) for Non-Microplasty UKRs (Figure 3). 252 
Microplasty UKRs had a significantly reduced revision rate compared with Non-Microplasty 253 
UKRs (HR=0.77, CI 0.64-0.94; p=0.008).  254 
 255 
Subgroup analysis of Microplasty UKR inserted within a year of its introduction (n=2,424) 256 
and those inserted more than a year after its introduction (n=5,529) had 4 year implant 257 
survival rates of 96.2% (CI 95.3-97.0) and 96.8% (CI 95.6-97.8) respectively (Figure 4). 258 
Microplasty UKRs inserted within one year of its introduction had non-significantly reduced 259 
revision rates when compared to Non-Microplasty UKRs (HR 0.86, CI 0.67-1.10, p=0.23). 260 
Microplasty UKRs inserted more than a year after its introduction had significantly reduced 261 
revision rates compared to Non-Microplasty (HR 0.69, CI 0.54-0.89, p=0.004).  262 
 263 
The revisions per 100 component years for Microplasty UKR (0.87, CI 0.75-1.02) were 264 
significantly lower (p=0.02) than for Non Microplasty (1.11, CI 0.99-1.24). Microplasty 265 
inserted within a year of its introduction (n=2,424) and those inserted more than a year and 266 
after its introduction (n=5,529) had revision rates per 100 component years of 0.98 (CI 0.78-267 
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1.22) and 0.79 (CI 0.63-0.99) respectively. When compared to the Non-Microplasty group, 268 
the decrease in revision rates of Microplasty inserted within a year of its introduction was not 269 
significant (0.98 v 1.11, p=0.34). Microplasty inserted more than a year after its introduction 270 
had significantly lower (0.79 v 1.11, p=0.008) revision rates than Non-Microplasty.  271 
 272 
The indications for revision with the highest revision rates per 100 component years in Non-273 
Microplasty UKRs were osteoarthritis progression (0.31), aseptic loosening (0.26) and pain 274 
(0.19) (Table 2). In Microplasty UKRs the highest revision rates per 100 component years 275 
were osteoarthritis progression (0.21), aseptic loosening (0.19) and pain (0.12) (Table 2). 276 
Microplasty UKRs had a significantly reduced revision risk per 100 component years 277 
compared to Non-Microplasty UKRs for indications; osteoarthritis progression (p<0.05, 0.21 278 
vs 0.31) and “other reasons” (p=0.003, 0.08 vs 0.18). Microplasty assisted UKRs had a 279 
significantly increased risk of periprosthetic fracture (p=0.03, 0.09 vs 0.04). No other revision 280 






















4. DISCUSSION  302 
 303 
This study demonstrates that Microplasty instrumentation improves the 5 year implant survival 304 
of the Oxford UKR compared to the Non-Microplasty instrumentation and decreases the 305 
overall revision rate by 23%. Although previous studies have demonstrated that Microplasty 306 
usage results in improvement in various surrogate measures such as implant positioning [13, 307 
14, 16], the need for tibial recuts [15] and tibial bone preservation [16], this is the first study 308 
which has investigated its effect on implant survival. 309 
 310 
We found different effects on revision rate with time from Microplasty introduction. 311 
Microplasty UKRs inserted less than a year after its introduction to a hospital decreased the 312 
revision rate compared to Non Microplasty UKRs by 14%. However the difference was not 313 
statistically significant, partly because the numbers of cases was relatively small, so we do not 314 
know if there was a decrease in revision rate or not. In contrast Microplasty UKRs inserted 315 
more than a year after its introduction had a 31% reduction in revision rates compared to Non-316 
Microplasty UKRs, which was highly statistically significant. The smaller decrease in revision 317 
rate during the first year after introduction is likely to be due, in part, to a delay in surgeons 318 
within a hospital changing to use Microplasty after the instruments had been supplied, as in 319 
many hospitals second and third Microplasty sets were introduced sometime after the first set. 320 
It may also, in part, be due to the learning curve. However as Microplasty, in the early period, 321 
did not increase the risk of revision relative to Non Microplasty the learning curve, if present, 322 
was not adverse as it was not associated with a temporary increase in implant failure rate.  323 
Furthermore the decrease in revision rate by one third (31%) seen later is likely to represent 324 
the true advantage of Microplasty.  325 
 326 
It is difficult to interpret the analysis of the causes for revision primarily because the average 327 
follow-up of the Microplasty (2.3 years) and Non-Microplasty (3.3 years) UKR were different. 328 
A direct comparison of revision rates would be inappropriate because the numbers of revisions 329 
are related to the length of follow-up. The optimal method of comparison would be Kaplan 330 
Meier survival with Cox regression models, which we used for primary analysis of overall 331 
revision rate, as this is designed for the analysis of data from patients with different lengths of 332 
follow-up. However, as the number of revisions in each subgroup is low, this method is not 333 
appropriate. Another widely used approach is to use the revision rate per 100 component years, 334 
which is what we have used. However it is based on the assumption that the annual revision 335 
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rate is constant. This a reasonable assumption for the overall revision rate and the conclusions 336 
of the analysis over the overall revision rate using revisions per 100 component years and 337 
survival and cox regression were identical. However although is a reasonable assumption for 338 
many individual modes of failure it may not be for all. For example peri-prosthetic fractures 339 
tend to occur early so the group with a shorter follow up would be expected to have a higher 340 
revision rate. This may explain why Microplasty has a peri-prosthetic fracture rate that is just 341 
significantly higher than that of Non-Microplasty. Conversely arthritis progression tends to 342 
occur late so the group with a longer follow up would be expected to have a higher revision 343 
rate. This may explain why Non-Microplasty has an arthritis progression rate that is just 344 
significantly higher than that of Microplasty. The only other significant difference relates to 345 
“other reasons” for revision, so we don’t know what these are. We therefore have to conclude 346 
that it is not clear why Microplasty has a lower revision rate but it is probably a result of the 347 
numerous improvements in the instruments.  348 
 349 
With the Non-Microplasty instrumentation surgeons judged the position of the tibial 350 
component and the orientation of the femoral component by eye. Microplasty includes a stylus 351 
system for selecting tibial resection level and a guide to control femoral component orientation. 352 
It has other advantages including slotted saw guides and instruments to protect the medial 353 
collateral ligament and avoid impingement. In addition, as the instrumentation guides 354 
component positioning the surgeon can focus on what really matters, which is restoration of 355 
normal ligament balance, tension and function. If these are accurately restored normal knee 356 
kinematics and function will also be restored. Previous studies have shown that the use of 357 
Microplasty does result in improved component positioning, with better tibial bone 358 
preservation, thinner bearings and avoidance of tibial recuts [13, 14, 16]. It has also resulted in 359 
improved patient reported outcome measures [15]. Furthermore Microplasty has made the 360 
operation more simple, logical, reliable and repeatable [13, 14]. These improvements probably 361 
explain the overall decrease in revision rate: For example improved component position and 362 
the avoidance of impingement should decrease revisions for loosening, pain and dislocation; 363 
and protection of the medial collateral ligament should prevent overcorrection and lateral 364 
arthritis. 365 
 366 
The main strength of the study is that it is large enough to study revision as it included over 367 
15,000 knees. The study is also unbiased as it was based on NJR data, and data from the 368 
designer surgeons centre was not included in the analysis. The study is also long enough to 369 
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report the 5 year revision rate and showed that it was appreciably less with Microplasty than 370 
Non-Microplasty Instrumentation. But perhaps more importantly the 97% five-year survival of 371 
Microplasty UKR was not substantially worse than that achieved by TKR in National Registers 372 
[4, 6]. So the Microplasty instrumentation has gone a long way to addressing the main 373 
disadvantage of UKR, which is that it has a higher revision rate than TKR. 374 
 375 
The main limitation of the study is that the precise date when individual surgeons changed 376 
from Non-Microplasty to Microplasty instrumentation is not known and the length of the 377 
learning curve is not known. As a result it was assumed that surgeons started using 378 
Microplasty as soon as it was introduced to their centre and that the transition period, which 379 
included the learning curve, lasted one year. Furthermore it is a possibility that some cases 380 
were done using other instrumentation, such as Patient Specific Instrumentation. However if 381 
other instrumentation was used the numbers would have been too small to influence the 382 
results. Another limitation is that the study is based on registry data and the only outcome 383 
assessed is revision. Furthermore the reasons for revision in the NJR are those recorded at the 384 
time of surgery even if this subsequently changed due to histopathology and microbiology 385 
data. Registries can under-report revisions [33] although there is no reason to believe this 386 
would differ between the groups, and it is not possible to confirm causality in registry based 387 
studies.  Another limitation is that, despite propensity matching there is potential for residual 388 
confounding. The groups were not perfectly matched given there was imbalance in the 389 
operating surgeon grade and surgeon caseload. However there were no differences in findings 390 
when we adjusted for these parameters in the regression models. There was a substantial 391 
proportion of BMI data missing so we did not match on BMI. However, the BMI distribution 392 
between groups were the same both before and after propensity matching. The only way to 393 
achieve complete balance with respect to both known and unknown confounders is with a 394 
randomised trial. However to compare revision rates and causes for revision would require 395 
large numbers which would make a randomised study impractical.  396 
 397 
 398 
5. CONCLUSIONS 399 
 400 
In conclusion, this propensity matched registry based study observed that the five year 401 
survival of Microplasty assisted Oxford UKRs was 97%, which was significantly better than 402 
that of Non-Microplasty UKRs. Furthermore there was no adverse learning curve effect. 403 
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After the one-year transition period, the revision rate following Microplasty UKRs was about 404 


























6. LIST OF TABLES 430 
 431 
Table 1. Patient and surgical factors before and after propensity score matching. 432 
Abbreviations: ASA (American Society of Anesthesiologist score), BMI (Body mass index), 433 
OA (Osteoarthritis), SD (Standard deviation), SMD (Standardised mean difference), UKR 434 
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Table 2. Reasons for revision in matched cohort. Comparisons between were Microplasty 438 
and Non-Microplasty revisions per 100 component years were conducted using the Chi squared 439 
test. Abbreviations: OA (Osteoarthritis), UKR (Unicompartmental Knee Replacement). 440 
Significant p values are in bold and the indication for revision they correspond to are marked 441 
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7. LIST OF FIGURES 447 
Figure 1. Schematic of Microplasty instrumentation. Adapted from [12]. 448 
 449 
Figure 2. Data flowchart of NJR database cleaning. 450 
 451 
Figure 3. Kaplan Meier implant survival rates for matched Microplasty assisted 452 
(n=7,953) and Non Microplasty (n=7,953) UKR implants up to 5 years. 453 
 454 
Figure 4. Kaplan Meier implant survival rates for Microplasty UKRs inserted < 1 year 455 
of introduction (n=2,424), Microplasty UKRs ≥ 1 year after introduction (n=5,529) and 456 
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